Apellis Pharmaceuticals, Inc. (APLS) Earnings
NASDAQ·Healthcare·Biotechnology
$40.95
+0.00%
Mkt Cap $5.23B
Next Earnings
In 7 daysWed, May 6, 2026
EPS Estimate
-$0.38
10 analysts
Revenue Estimate
$203.58M
Last quarter: missed by -20.51% on EPS, +0.26% on revenue.
EPS — Estimate vs Actual
Mkt Cap
$5.23B
P/E
240.82
Fwd P/E
72.59
P/S
5.21
Rev TTM
—
EPS TTM
$0.17